Galactose Residues on the Lipooligosaccharide ofMoraxella catarrhalis26404 Form the Epitope Recognized by the Bactericidal Antiserum from Conjugate Vaccination
Authors:
- 1 September 2008
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 76 (9) , 4251-4258
Abstract
Lipooligosaccharide (LOS) fromMoraxella catarrhalishas the potential to elicit bactericidal antibodies against the pathogen. We generated LOS-based conjugate vaccines that elicited bactericidal antibodies in animal models. However, epitopes on the LOS recognized by the functional anti-LOS antibodies remain unidentified. In this study, a mutant strain, D4, which lost the recognition by a bactericidal anti-LOS rabbit serum in Western blotting was generated from a serotype C strain 26404 by random transposon mutagenesis. Sequence analysis revealed there was an insertion of a kanamycin resistance gene in thelgt2gene of D4, which encodes β(1-4)-galactosyltransferase. An isogeniclgt2mutant, 26404lgt2, was constructed. Structural analysis indicated that the mutant strain produced a truncated LOS lacking terminal galactoses from 4- and 6-linked oligosaccharide chains of strain 26404. Further studies showed that the antiserum lost the recognition of both mutant cells and LOSs in Western blotting, an enzyme-linked immunosorbent assay (ELISA), or a flow cytometry assay. The antiserum also lost the ability to kill the mutant strain in a bactericidal assay, whereas it showed a bactericidal titer of 1:80 to strain 26404. In an inhibition ELISA,d-(+)-galactose or 26404lgt2 LOS showed no inhibition. However, the 26404 LOS and a serotype A O35E LOS with terminal galactoses on its 6-linked oligosaccharide chain showed >90% inhibition, while a serotype B 26397 LOS showed >60% inhibition. These studies suggest that the terminal α-Gal-(1→4)-β-Gal on the 6-linked oligosaccharide chain of 26404 LOS plays a critical role in forming the epitope recognized by the bactericidal antiserum induced by immunization with our conjugate vaccine.Keywords
This publication has 42 references indexed in Scilit:
- Biological and Immunological Characteristics of Lipooligosaccharide-Based Conjugate Vaccines for Serotype C Moraxella catarrhalisInfection and Immunity, 2007
- Roles of 3-Deoxy- d - manno -2-Octulosonic Acid Transferase from Moraxella catarrhalis in Lipooligosaccharide Biosynthesis and VirulenceInfection and Immunity, 2005
- Characterization of a Cluster of Three Glycosyltransferase Enzymes Essential for Moraxella catarrhalis Lipooligosaccharide AssemblyJournal of Bacteriology, 2005
- Synthesis and Characterization of Lipooligosaccharide-Based Conjugate Vaccines for Serotype B Moraxella catarrhalisInfection and Immunity, 2005
- The Hag Protein ofMoraxella catarrhalisStrain O35E Is Associated with Adherence to Human Lung and Middle Ear CellsInfection and Immunity, 2003
- Specific Immune Responses and Enhancement of Murine Pulmonary Clearance of Moraxella catarrhalis by Intranasal Immunization with a Detoxified Lipooligosaccharide Conjugate VaccineInfection and Immunity, 2002
- Functional Characteristics of a Protective Monoclonal Antibody against Serotype A and C Lipooligosaccharides from Moraxella catarrhalisInfection and Immunity, 2001
- Lipooligosaccharide P k (Galα1-4Galβ1-4Glc) Epitope of Moraxella catarrhalis Is a Factor in Resistance to Bactericidal Activity Mediated by Normal Human SerumInfection and Immunity, 2000
- Enhancement of Clearance of Bacteria from Murine Lungs by Immunization with Detoxified Lipooligosaccharide fromMoraxella catarrhalisConjugated to ProteinsInfection and Immunity, 2000
- Use of Serology to Diagnose Pneumonia Caused by Nonencapsulated Haemophilus influenzae and Moraxella catarrhalisThe Journal of Infectious Diseases, 1994